Skip to main content
. 2020 Sep 24;163:1687–1696. doi: 10.1016/j.ijbiomac.2020.09.138

Fig. 6.

Fig. 6

Molecular docking views of drugs in the ATP-binding site of mutant SARS-CoV2 helicase. (a) Surface (right) and cartoon (left) views of the all poses in the cleft. (b) Fludarabine, (c) cangrelor, (d) polydatin, (e) folic acid.